Parents of a school-age child with hemophilia ask the nurse, "Which sports are recommended for children with hemophilia?" Which sport should the nurse recommend?

Choice A rationale:

The correct answer. Surfactant is a substance that decreases surface tension in the alveoli of the lungs, preventing them from collapsing and sticking together. By improving the ability of the baby's lungs to exchange oxygen and carbon dioxide, surfactant therapy helps the infant breathe more effectively.

Choice B rationale:

Surfactant therapy is not related to sedation. Its primary function is to assist with lung function, not sedation.

Choice C rationale:

Surfactant therapy does not specifically address apnea. Its main purpose is to enhance the respiratory function of premature infants.

Choice D rationale:

Surfactant therapy is not used to fight respiratory tract infections. It is a treatment focused on improving the respiratory distress syndrome in premature infants.

Choice A rationale:

A stat magnesium sulfate level (Choice A) is unnecessary in this situation. The symptoms described - increased temperature, pulse rate, and blood pressure, along with absent deep tendon reflexes - indicate magnesium sulfate toxicity. Discontinuing the infusion and managing the symptoms take precedence over checking the magnesium sulfate level.

Choice B rationale:

Administering oxygen (Choice B) is important for maintaining the patient's oxygenation levels, but it does not address the magnesium sulfate toxicity. The primary intervention should be to discontinue the infusion and manage the symptoms.

Choice C rationale:

Discontinuing the magnesium sulfate infusion (Choice C) is the correct action in this situation. The symptoms, including absent deep tendon reflexes and the patient's complaint of thirst and warmth, indicate magnesium sulfate toxicity. Stopping the infusion is crucial to prevent further complications.

Choice D rationale:

Hydralazine (Choice D) is an antihypertensive medication and is not the appropriate intervention for magnesium sulfate toxicity. Managing magnesium sulfate toxicity involves discontinuing the infusion and providing supportive care.